Abstract：Cancer is one of the most lethal diseases in China. Prevention, early detection and early treatment are the keys to cancer control. Cancer screening relies on techniques such as visualization, radiographic imaging, cancer biomarker measuring, directly or indirectly looking for cancer in people who have no symptoms. Screening can reduce cancer morbidity and mortality, since the treatment of cancer at early stage is less aggressive and more effective. Lung cancer, gastric cancer, liver cancer, esophageal cancer and colorectal cancer are cancers with the highest morbidity and mortality in China, while abundant evidence suggests that screening and early treatment of these cancers can significantly improve the prognosis of patients. In addition, breast cancer and cervical cancer also have a relatively high incidence in female, and simultaneously with mature screening and prevention methods. According to Chinese national condition, with reference to the cancer screening evidence together with the cancer screening guidelines existed, it is recommended to start the early screening of lung cancer, breast cancer, gastric cancer, esophageal cancer, liver cancer, colorectal cancer, cervical cancer in China.
孔梓任 王裕 马文斌 王任直. 癌症筛查在中国的开展前景[J]. 中国医药导报, 2018, 15(9): 167-171.
KONG Ziren WANG Yu MA Wenbin WANG Renzhi. Prospects of cancer screening in China. 中国医药导报, 2018, 15(9): 167-171.
[1] Siegel RL，Miller KD，Jemal A. Cancer statistics，2018 [J]. CA Cancer J Clin，2018，68（1）：7-30.
[2] Chen W，Zheng R，Baade PD，et al. Cancer statistics in China，2015 [J]. CA Cancer J Clin，2016，66（2）：115-132.
[3] Ilbawi AM，Anderson BO. Cancer in global health：how do prevention and early detection strategies relate? [J]. Sci Transl Med，2015，7（278）：278-278.
[4] Loud JT，Murphy J. Cancer screening and early detection in the 21（st） Century [J]. Semin Oncol Nurs，2017，33（2）：121-128.
[5] Shieh Y，Eklund M，Sawaya GF，et al. Population-based screening for cancer：hope and hype [J]. Nat Rev Clin Oncol，2016，13（9）：550-565.
[6] Harris RP，Wilt TJ，Qaseem A. A value framework for cancer screening：advice for high-value care from the American College of Physicians [J]. Ann Intern Med，2015， 162（10）：712-717.
[7] Smith RA，Andrews KS，Brooks D，et al. Cancer screening in the United States，2017：A review of current American Cancer Society guidelines and current issues in cancer screening [J]. CA Cancer J Clin，2017，67（2）：100-121.
[8] Wender R，Fontham ET，Barrera E，et al. American Cancer Society lung cancer screening guidelines [J]. CA Cancer J Clin，2013，63（2）：107-117.
[9] Wiener RS，Gould MK，Arenberg DA，et al. An official American Thoracic Society/American College of Chest Physicians policy statement：implementation of low-dose computed tomography lung cancer screening programs in clinical practice [J]. Am J Respir Crit Care Med，2015， 192（7）：881-891.
[10] Blackmon SH，Feinglass SR. The United States Preventive Services Task Force recommendations for lung cancer screening [J]. Thorac Surg Clin，2015，25（2）：199-203.
[11] Brawley OW. Lung cancer screening：Summary of the evidence and the 2013 US preventative services task force recommendations [J]. Cancer Forum，2014，38（3）：224-226.
[12] Oeffinger KC，Fontham ET，Etzioni R，et al. Breast Cancer Screening for Women at Average Risk：2015 Guideline Update From the American Cancer Society [J]. Jama，2015，314（15）：1599-1614.
[13] Lauby-Secretan B，Scoccianti C，Loomis D，et al. Breast-cancer screening——viewpoint of the IARC Working Group [J]. N Engl J Med，2015，372（24）：2353-2358.
[14] Siu AL. Screening for Breast Cancer：U.S. Preventive Services Task Force Recommendation Statement [J]. Ann Intern Med，2016，164（4）：279-296.
[15] Hamashima C，Shibuya D，Yamazaki H，et al. The Japanese Guidelines for Gastric Cancer Screening [J]. Jpn J Clin Oncol，2008，38（4）：259-267.
[16] Hamashima C，Goto R. Potential capacity of endoscopic screening for gastric cancer in Japan [J]. Cancer Sci，2017， 108（1）：101-107.
[17] Choi KS，Jun JK，Suh M，et al. Effect of endoscopy screening on stage at gastric cancer diagnosis：results of the National Cancer Screening Programme in Korea [J]. Br J Cancer，2015，112（3）：608-612.
[18] Leung WK，Wu MS，Kakugawa Y，et al. Screening for gastric cancer in Asia：current evidence and practice [J]. Lancet Oncol，2008，9（3）：279-287.
[19] Sun X，Chen W，Chen Z，et al. Population-based case-control study on risk factors for esophageal cancer in five high-risk areas in China [J]. Asian Pac J Cancer Prev，2010， 11（6）：1631-1636.
[20] 王国清，魏文强，郝长青，等.食管癌在食管黏膜上最初起源点的高发现场前瞻性研究[J].中华肿瘤杂志，2010， 32（3）：196-198.
[21] Yang J，Wei WQ，Niu J，et al. Cost-benefit analysis of esophageal cancer endoscopic screening in high-risk areas of China [J]. World J Gastroenterol，2012，18（20）：2493-2501.
[22] Chen Q，Yu L，Hao C，et al. Effectiveness evaluation of organized screening for esophageal cancer：a case-control study in Linzhou city，China [J]. Sci Rep，2016，6：35707.
[23] Wei WQ，Chen ZF，He YT，et al. Long-term follow-up of a community assignment，one-time endoscopic screening study of esophageal cancer in China [J]. J Clin Oncol，2015， 33（17）：1951-1957.
[24] Chen JG，Zhang SW. Liver cancer epidemic in China：past，present and future [J]. Semin Cancer Biol，2011，21（1）：59-69.
[25] Lee EH，Han MA，Lee HY，et al. Liver cancer screening in Korea：a report on the 2008 National Cancer Screening Programme [J]. Asian Pac J Cancer Prev，2010，11（5）：1305-1310.
[26] Yeh YP，Hu TH，Cho PY，et al. Evaluation of abdominal ultrasonography mass screening for hepatocellular carcinoma in Taiwan [J]. Hepatology，2014，59（5）：1840-1849.
[27] Zhang BH，Yang BH，Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma [J]. J Cancer Res Clin Oncol，2004，130（7）：417-422.
[28] Kudo M，Matsui O，Izumi N，et al. Surveillance and diagnostic algorithm for hepatocellular carcinoma proposed by the Liver Cancer Study Group of Japan：2014 update [J]. Oncology，2014，87 Suppl 1：7-21.
[29] Levin B，Lieberman DA，McFarland B，et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps，2008：a joint guideline from the American Cancer Society，the US Multi-Society Task Force on Colorectal Cancer，and the American College of Radiology [J]. Gastroenterology，2008，134（5）：1570-1595.
[30] von Karsa L，Patnick J，Segnan N，et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis：overview and introduction to the full supplement publication [J]. Endoscopy，2013，45（1）：51-59.
[31] Bretthauer M. Evidence for colorectal cancer screening [J]. Best Pract Res Clin Gastroenterol，2010，24（4）：417-425.
[32] Waggoner SE. Cervical cancer [J]. Lancet，2003，361（9376）：2217-2225.
[33] Saslow D，Solomon D，Lawson HW，et al. American Cancer Society，American Society for Colposcopy and Cervical Pathology，and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer [J]. Am J Clin Pathol，2012，137（4）：516-542.
[34] Wang X，Song X，Zhuo W，et al. The regulatory mechanism of Hsp90alpha secretion and its function in tumor malignancy [J]. Proc Natl Acad Sci U S A，2009，106（50）：21288-21293.
2018, Vol. 15 
京公网安备 11010502046598号